XML 20 R47.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 12 Months Ended 3 Months Ended
Mar. 31, 2012
Dec. 31, 2011
Mar. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Restricted Stock [Member]
Mar. 31, 2012
Restricted Stock [Member]
Mar. 31, 2013
Retiring named executive officers [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares authorized for grant     12,500,000        
Shares available for future issuance     1,500,000        
Options Roll Forward              
Shares outstanding under option, Beginning Balance       1,436,000      
Weighted average exercise price, Beginning Balance       $ 30.65      
Shares outstanding under option, Exercised (81,000)            
Shares outstanding under option, Exercised, Weighted average exercise price $ 28.43            
Shares outstanding under option, Ending Balance 1,355,000     1,436,000      
Weighted average exercise price, Ending Balance $ 30.78     $ 30.65      
Weighted average remaining contractual term 3 years 2 months 3 years 5 months          
Aggregate intrinsic value, outstanding $ 63.1     $ 58.8      
Restricted stock compensation expense              
Restricted stock compensation expense         $ 11.1 $ 4.7 $ 5.5
Status of nonvested restricted stock              
Nonvested shares subject to restriction, Beginning Balance       1,032,000      
Nonvested shares subject to restriction, weighted average exercise price       $ 58.77      
Restricted shares granted to employees 372,000       371,697    
Granted shares subject to restriction, weighted average exercise price $ 75.41            
Shares subject to restriction, Vested (331,000)            
Vested shares subject to restriction, weighted average exercise price $ 47.69            
Shares subject to restriction, Forfeited (19,000)            
Forfeited shares subject to restriction, weighted average exercise price $ 68.14            
Nonvested shares subject to restriction, Ending Balance 1,054,000     1,032,000      
Nonvested shares subject to restriction, weighted average exercise price $ 67.71     $ 58.77